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Abstract Introduction: Desmoplas-
tic infantile gangliogliomas (DIG)
are rare cerebral glioneural tumors
usually occurring in early childhood.
DIGs are generally benign although
rare cases with poor outcome are
known. Total resection, if possible,
is the treatment of choice, without
further adjuvant therapy. After in-
complete resection, adjuvant chemo-
and/or radiotherapy is generally ap-
plied, despite the potential negative
side effects in such young patients.
Case reports: We describe two girls
with DIG, one who twice underwent
subtotal resection at 3 and 5 months,
the other who underwent total resec-
tion at 2 years. Neither had adjuvant
therapy and there was no tumor re-
currence. Conclusions: Our own 
experience and a review of the liter-
ature suggest that in most DIGs 
adjuvant therapy is not justified
even after incomplete resection. 
After tumor recurrence a second 
surgical intervention should be con-
sidered instead of adjuvant therapy.
An exception may be made for rare,
deep-seated DIGs, which are more
aggressive and have a poorer out-
come.
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Introduction
Desmoplastic infantile gangliogliomas (DIGs) are rare
neoplasms that were first described by VandenBerg 
et al. in 1987 [19]. They typically occur in infants 
under 2 years. However, three cases of young adults
(14–19 years) have also been recently reported, so that
DIG does not seem to be a specific entity of infancy [5,
12, 20]. The huge size and relative lack of obtundation
with such large masses suggest very slow growth, and the
early age of onset has led to the speculation that this tu-
mor could be of congenital origin [14]. At presentation
the tumor is usually very large (up to 13 cm diameter),
with associated cysts and attachment to the dura. The su-
pratentorial region is preferentially involved, especially
the frontal and parietal lobes, followed by the temporal
[17], and rarely the occipital region. The symptoms,
which usually appear soon after birth, include increasing
head circumference, bulging fontanel, sunset sign, hemi-
paresis, and frequent seizures (irritation of surrounding
brain or neuronal components may also be intrinsically
epileptogenic). On MRI these tumors are radiologically
characterized by a hypointense cystic mass with an isoin-
tense peripheral solid component on the T1-weighted
scan that enhances with gadolinium; on T2-weighted im-
ages the cystic component is hyperintense and the solid
portion is heterogeneous. The cysts are generally large,
uni- or multiloculated, with clear or xanthochronic fluid.
The solid superficial extracerebral part of the tumor is
firm or rubbery in consistency, gray or white in color, and
typically with dural attachment. Histologically, the tu-
mors are characterized by a prominent desmoplastic stro-
ma and mixture of neoplastic astrocytes and neuronal
cells at varying stages of differentiation [14]. Mitotic ac-
tivity is very low, and there is usually no necrosis. How-
ever, when present, mitoses and foci of necrosis are most-
ly restricted to areas with poorly differentiated neuroepi-
thelial cells and they are not considered to be anaplastic
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or malignant features. Recently, the formerly termed
“desmoplastic infantile neuroepithelial tumors”, either
with or without ganglion cells, have been grouped collec-
tively as “desmoplastic infantile astrocytoma (DIA) and
ganglioglioma (DIG)”, and included in common classifi-
cations of cerebral tumors [7, 11, 17]. Up to now about
60 cases of DIA/DIG have been described [14]. Whether
DIA indeed represents a separate entity, or is just a form
of DIG in which neurons have not been detected in the
biopsied tissue, is a matter of debate [10, 14].
If possible, the preferred treatment of DIGs is total
surgical resection. There is no unique practice in cases in
which only incomplete resection has been carried out.
Adjuvant chemotherapy and/or radiotherapy have been
administered in most of these cases, with a maximal fol-
low-up of 14 years. In this paper we describe two DIG
patients, one with subtotal and one with total surgical re-
section, both of whom had a favorable outcome without
adjuvant therapy.
Case reports
Case 1
Pregnancy was uneventful. At birth, this girl had a wide non-reac-
tive pupil on the left side and paresis of the superior musculus rec-
tus. These symptoms were interpreted as a birth trauma. Later
hemiparesis developed on the right side. Neuropediatric consulta-
tion led to MRI, which revealed a large cystic tumor (7×5 cm)
with inhomogeneous gadolinium enhancement, which completely
filled the left hemisphere and caused a marked midline shift
(Fig. 1A). The child was admitted to our Neurosurgical Clinic at
the age of 3 months. The fontanel was plane, there was no patho-
logical growth of the head, but clinically there was left-sided
amaurosis, VII paresis on the left and hemiparesis on the right.
Preoperative angiography showed a marked tumor blush, the
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Fig. 1A–D Desmoplastic infantile ganglioglioma (DIG) in the 
left hemisphere of a 3-month-old girl. A Coronal post-contrast 
T1-weighted MRI scan showing a huge cystic tumor with typical
dural attachment and midline shift. B Digital subtraction cerebral
angiogram. C Coronal MRI scan after first operation with incom-
pletely resected tumor. D Coronal post-contrast MRI scan 4 years
after surgery without tumor recurrence
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Fig. 2A–C Right occipital DIG
in a 2-year-old girl. A Coronal
post-contrast T1-weighted MRI
scan with huge cystic tumor
right parieto-occipital with 
extensive dural attachment 
on the tentorium. B Digital
substraction cerebral angiogram.
C Coronal MRI 3 months post-
operatively without tumor 
recurrence
branches of the middle cerebral artery were displaced towards the
front and there was a large vein draining into the left transverse 
sinus (Fig. 1B). The tumor, which was attached to the dura, was
composed of multiple cysts and soft fleshy tumor tissue with cal-
cification and signs of previous hemorrhages. Because of the at-
tachment to the middle cerebral artery and branches of the posteri-
or cerebral artery, the tumor could not be completely resected. The
child recovered well, and postoperatively the hemiparesis was 
reduced, but the left-sided amaurosis remained. Epileptic seizures
were successfully treated with valium infusions and a diabetes in-
sipidus was substituted. A control MRI showed left fronto-parietal
remains of the tumor , with a midline shift (Fig. 1C). In a second
operation 2 months later some of the tumor and cyst were re-
moved, but the rest attached to the arteries had to be left. Because
of new cyst formation, a cysto-peritoneal drainage was inserted.
Recovery was good, without any further neurological deficits.
MRI control studies have been carried out at 3-month intervals.
MRI 4 years after surgery showed no pathological contrast en-
hancement and no tumor recurrence (Fig. 1D).
Case 2
A 2-year-old girl, whose birth and family history were unremark-
able, developed partial seizures on the left hand lasting for 30 min.
She was admitted to our Children’s Hospital, where again a partial
seizure on the left side occurred (arm and leg). The neurological
examination showed a homonymous hemianopsia on the left side,
with no further neurological deficits. MRI showed a huge cystic,
right parietal-occipital tumor with typical dural attachment and in-
homogeneous contrast enhancement. There was little edema and a
slight midline shift (Fig. 2A). Preoperative angiography showed a
huge avascular, right parieto-occipital tumor with displacement of
the right posterior cerebral artery towards the cranial. There was
no tumor blush and no patency of the transverse sinus (Fig. 2B).
The tumor could be completely resected. Because of the extensive
dural attachment to the tentorium, resection was only possible step
by step because of repeated bleeding. Postoperatively, the child 
recovered well, although the left homonymous hemianopsia per-
sisted. Under phenobarbital medication no seizures occurred. In
the 3-month follow-up there was no tumor recurrence (Fig. 2C).
Material and methods
Sections (4 µm thick) were prepared from formalin-fixed/paraffin-
embedded specimens and were stained with hematoxylin and eosin,
Masson’s trichom and reticulin stains. Immunohistochemistry was
performed using primary antibodies (monoclonal, unless otherwise
specified): neuron-specific enolase (NSE; 1:8000; Dako, Copen-
hagen, Denmark), glial fibrillary acidic protein (GFAP, polyclonal;
1:200; Dako); synaptophysin (1:200; Dako), neurofilament (1:500;
Bio-Genex, San Ramon, CA), epithelial membrane antigen (EMA;
1:50; Dako) and MIB-1 (1:800; Dianova, Hamburg, Germany).
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Fig. 3A–F Desmoplastic infantile ganglioglioma. Histology and
immunohistochemistry. A Astrocytic tumor cells within marked
desmoplastic areas. B Collagen and reticulum fibers surrounding
tumor cells. C Tumor regions with many ganglion and ganglion-
like cells. D Foci with aggregates of poorly differentiated neuro-
epithelial cells. E Glial fibrillary acidic protein immunoreactive
neoplastic astrocytes. F Synaptophysin staining of ganglion cells
and their process. A–F ×220; A–D H&E stains
Results
Histology
The multiple tissue fragments from both children
showed largely similar histological features, consisting
mainly of spindle, elongated tumor cells arranged in fas-
cicles or in a storiform pattern (Fig. 3A), intermixed with
collagen and reticulum fibers surrounding tumor cells
(Fig. 3B). Some cells also resembled gemistocytes. In
addition, larger ganglion-like cells were found in areas
with scanty extracellular matrix (Fig. 3C). To variable
extents, aggregates of poorly differentiated cells with
small basophilic nuclei and minimal surrounding peri-
karya were present in both cases (Fig. 3D). Overall,
however, cellularity and pleomorphism were moderate,
mitoses were very rare and necrosis was absent.
Immunohistochemistry
Most of the spindle shaped cells in the desmoplastic stro-
ma and the larger gemistocytes stained strongly for
GFAP (Fig. 3E) while such an immunoreactivity was on-
ly found in a small subset of the poorly differentiated
cells. The ganglion cells stained intensely for NSE and
synaptophysin (Fig. 3F). Only a few small ganglion cell
processes stained for neurofilament. All tumor cells were
negative for EMA. In both tumors the mean MIB-1 pro-
liferation rate was 1.5%.
The diagnosis of desmoplastic infantile ganglioglio-
ma was confirmed by the Armed Forces Institute of 
Pathology (AFIP) in case 1 (AFIP Accession number
268098) and by the German Reference Center for Brain
Tumors in case 2 (Accession number R-21517).
Discussion
Desmoplastic infantile gangliogliomas are rare cerebral
tumors classified as WHO grade I with a generally ex-
cellent prognosis [1, 18, 19]. Many reports deal with his-
tological, immunohistochemical, ultrastructural and/or
molecular aspects and there is not much information
about the management and therapeutic strategies of these
tumors.
Although DIGs are considered to be benign tumors,
some cases may exhibit at least focal histological fea-
tures (e.g. aggregates of poorly differentiated cells with
low to moderate mitotic activity, foci of necrosis) that
may lead to the erroneous diagnosis of malignancy [11,
16, 19]. Since there is usually long-term survival after
gross total resection, these changes are not considered to
be anaplastic or malignant. Moreover, proliferation rates
in DIGs are usually low with reported Ki-67 labeling in-
dices ranging between 0.5 and 5% [1, 6, 20]. However,
DIGs with overt anaplastic and malignant histological
features, including necrosis with pseudopalisading of 
tumor cells, vascular proliferation, high mitotic rate and
high Ki-67 labeling indices have also been described [1,
8, 9]. It is of interest that the outcome of these cases
seems to be dependent on the location of the tumor. Thus
the two anaplastic DIG cases with superficially located
tumors reported by Kuchelmeister et al. [9] did not show
recurrence after gross complete removal without further
adjuvant therapy. In contrast, the unusual deeply seated
anaplastic DIG case reported by De Munnynck et al. 
[1], presenting with intracerebral and pial metastases,
showed an aggressive behavior after incomplete resec-
tion and adjuvant chemotherapy. A DIG case with deep
tumor location but no anaplastic features was also re-
ported, which finally led to death after incomplete resec-
tion and adjuvant chemotherapy [6, 13]. Similarly, there
is a report of a deeply located desmoplastic infantile as-
trocytoma lacking anaplastic features, which presented
with CSF dissemination and resulted in a poor outcome
[15]. An additional deeply seated DIG involving the
brainstem has recently been reported by Fan et al. [4].
Although there were no anaplastic features in this case,
there was rapid tumor progression even after near-total
resection and aggressive chemotherapy. A more favor-
able outcome for two deep-seated DIGs, one of them
with anaplastic histological features, was reported by
Duffner et al. [2]. In both cases more than 75% of the tu-
mor could be resected and chemotherapy was applied.
An overview of the literature about deep-seated DIGs/
DIAs is given in Table 1.
Based on these findings we can conclude—most like-
ly irrespective of the presence of histological anaplastic
features—that the outcome of DIGs is at least partially
determined by the tumor location. DIGs with a superfici-
al location amenable to total gross surgical resection
have a favorable prognosis, while DIGs with a deep lo-
cation (possibly accompanied by CSF dissemination)
show more aggressive behavior with a probably fatal
outcome [4, 15].
At the moment there are no molecular genetic data
that would enable us to predict tumor progression in
DIGs [7].
The treatment of choice is complete surgical resec-
tion, if possible. Because most of the patients are very
young, careful surgical planning and management are
necessary. Two cases of death during surgery have been
described [11, 16]. The extent of the surgical challenge
and blood loss should not be underestimated in this pop-
ulation of patients. It is essential to know the relationship
of the tumor to the sinuses and deeper vascular struc-
tures, and if this cannot be adequately seen on MRI it
would be wise to perform preoperative angiography.
With reference to the Low Grade Glioma Study, we
decided in our cases to carry out a follow-up with only
3-monthly MRIs without any additional therapy. No tu-
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mor recurrence was seen in either case 1 with subtotal
resection and a 4-year follow-up or in case 2 with total
resection and a 3-month follow-up.
The use of adjuvant therapy is still controversial, 
especially in incompletely resected tumors. The value of
radiotherapy has not been established [2, 4, 11, 18], al-
though chemotherapy may be required in cases of pro-
gressive disease with anaplastic features. There are not
many reports dealing with the side effects of these types
of treatment in children under 2 years. Four of out of
five second malignancies occurred in children younger
than 2 years of age at diagnosis with a cumulative risk at
8 years of 18.9% (CI 0–70%) [3].
Considering the young age of most patients and the
danger of side-effects, we conclude from the available lit-
erature and our own experience that only follow-up by im-
aging is justified in these partially resected DIGs [3, 11,
14]. In cases where the tumor cannot be completely re-
moved in one step the child should be allowed to recover
and a second operation should be considered, as in our
first case. In Fig. 4 we show a therapeutic plan for the
management of a desmoplastic infantile ganglioglioma.
There may be a need for adjuvant chemotherapy in
cases of deep seated tumors with aggressive behavior.
However, because of the small number of patients, our
conclusions should be interpreted with caution and fur-
ther investigations are needed. We should think about a
multicentric interdisciplinary study group that could col-
lect data and give advice about the therapy for these rare
tumors.
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Fig. 4 Therapeutic plan for
desmoplastic infantile ganglio-
glioma
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